Ads
related to: viking therapeutics stockinvesco.com has been visited by 1M+ users in the past month
Search results
Is Viking Therapeutics Stock a Buy? | The Motley Fool
The Motley Fool· 2 days agoInvestors have been bullish about Viking Therapeutics (VKTX -2.98%) of late, but it's still a...
Viking Therapeutics (NASDAQ:VKTX) Lifted to Strong-Buy at Raymond James
ETF DAILY NEWS· 10 hours agoRaymond James upgraded shares of Viking Therapeutics (NASDAQ:VKTX – Free Report) from an outperform rating to a strong-buy rating in a report released on ...
Should You Hold Viking Therapeutics (VKTX) in Your Portfolio?
Zacks via Yahoo Finance· 4 days agoViking Therapeutics' (VKTX) lead candidate for obesity, VK2735, is expected to have tremendous...
3 Monster Stocks in the Making You Can Buy Right Now | The Motley Fool
The Motley Fool· 1 day agoStocks can be like this, beginning small but growing to a giant size over time. Here's why they...
Smart Money Is Betting Big In VKTX Options - Viking Therapeutics (NASDAQ:VKTX)
Benzinga· 2 days agoThe company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214.
4 Stocks That Could Break Novo Nordisk, Lilly's Obesity Duopoly
Zacks via Yahoo Finance· 2 days agoThough obesity drugs continue to gain traction, it is currently a duopoly market. As analysts expect...
Pharma Stocks Outlook: Where Are 2024's Top Performers Headed Next?
InvestorPlace· 2 days agoWhile a conservative investor might suggest that such growth is unsustainable, each of those firms...
Double-Up Delights: 7 Stocks Poised to Soar 100% by 2025
InvestorPlace· 5 days agoEvery investor wants their stock picks to double in price. At that rate the law of 72 states that an investor can expect their capital to double roughly every 7 years. There ...
Roche’s New Weight-Loss Data Shows Lilly Isn’t Unbeatable in Obesity
Barrons.com· 3 days agoHe said they were in line with data on a promising experimental weight-loss drug from Viking ...
Eli Lilly falls on a rival's obesity study — plus, we're removing 3 stocks from our watchlist
CNBC· 3 days agoIt's not a surprise to see Lilly's stock down on the threat of another new potential entrant to the...
